These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 32835666)
21. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. Seltzer S Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735 [TBL] [Abstract][Full Text] [Related]
22. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2. Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084 [TBL] [Abstract][Full Text] [Related]
23. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19. Salah HM; Mehta JL J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):114-118. PubMed ID: 33078623 [TBL] [Abstract][Full Text] [Related]
24. Interaction of COVID-19 With Common Cardiovascular Disorders. Boulos PK; Freeman SV; Henry TD; Mahmud E; Messenger JC Circ Res; 2023 May; 132(10):1259-1271. PubMed ID: 37167359 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases. Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851 [TBL] [Abstract][Full Text] [Related]
32. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis. Zhao YH; Zhao L; Yang XC; Wang P Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257 [TBL] [Abstract][Full Text] [Related]
33. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740 [TBL] [Abstract][Full Text] [Related]
34. COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations. Shu H; Wen Z; Li N; Zhang Z; Ceesay BM; Peng Y; Zhou N; Wang DW Aging Dis; 2023 Dec; 14(6):2071-2088. PubMed ID: 37199573 [TBL] [Abstract][Full Text] [Related]
35. Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023. Zhou S; Zhang A; Liao H; Liu Z; Yang F Cardiology; 2024; 149(1):60-70. PubMed ID: 37586358 [TBL] [Abstract][Full Text] [Related]
37. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes. Kaye AD; Spence AL; Mayerle M; Sardana N; Clay CM; Eng MR; Luedi MM; Carroll Turpin MA; Urman RD; Cornett EM Best Pract Res Clin Anaesthesiol; 2021 Oct; 35(3):437-448. PubMed ID: 34511231 [TBL] [Abstract][Full Text] [Related]
38. The effect of cardiovascular disease and acute cardiac injury on fatal COVID-19: a meta-analysis. Long J; Luo Y; Wei Y; Xie C; Yuan J Am J Emerg Med; 2021 Oct; 48():128-139. PubMed ID: 33895644 [TBL] [Abstract][Full Text] [Related]
39. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Bucciarelli V; Nasi M; Bianco F; Seferovic J; Ivkovic V; Gallina S; Mattioli AV Trends Cardiovasc Med; 2022 Jan; 32(1):12-17. PubMed ID: 34619336 [TBL] [Abstract][Full Text] [Related]
40. Cardiac arrhythmias associated with COVID-19 infection: state of the art review. Mohammad M; Emin M; Bhutta A; Gul EH; Voorhees E; Afzal MR Expert Rev Cardiovasc Ther; 2021 Oct; 19(10):881-889. PubMed ID: 34702128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]